The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $70.90

Today's change-0.10 -0.14%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $70.90

Today's change-0.10 -0.14%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

PAREXEL International Corp down (U.S.)$0.10

PAREXEL International Corp closed lower Thursday, dropping (U.S.)$0.10 or 0.14% to (U.S.)$70.90. Shares have lost 0.56% for the last five days, but sit just 1.96% below their 52-week high. This security has underperformed the S&P 500 by 10.54% during the last year.

Key company metrics

  • Open(U.S.) $71.05
  • Previous close(U.S.) $71.00
  • High(U.S.) $71.54
  • Low(U.S.) $70.66
  • Bid / Ask-- / --
  • YTD % change+7.88%
  • Volume849,657
  • Average volume (10-day)779,467
  • Average volume (1-month)795,998
  • Average volume (3-month)785,982
  • 52-week range(U.S.) $51.16 to (U.S.) $72.32
  • Beta0.82
  • Trailing P/E22.66×
  • P/E 1 year forward18.96×
  • Forward PEG1.29×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.13
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.08%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue577626611604
Total other revenue--------
Total revenue577626611604
Gross profit169189190188
Total cost of revenue407436421416
Total operating expense523561542550
Selling / general / administrative92969797
Research & development--------
Depreciation / amortization25252424
Interest expense (income), net operating--------
Unusual expense (income)-14-210
Other operating expenses, total--------
Operating income53647055
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax50606752
Income after tax38434839
Income tax, total12171913
Net income38434839
Total adjustments to net income--------
Net income before extra. items38434839
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items38434839
Inc. avail. to common incl. extra. items38434839
Diluted net income38434839
Dilution adjustment--------
Diluted weighted average shares54535454
Diluted EPS excluding extraordinary itemsvalue per share0.700.800.890.73
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.690.860.870.87